Authors


Rebecca Fallis, MD

Latest:

Final Diagnosis: Pott Puffy Tumor With Subdural Empyema

A rare case of Pott puffy tumor occurs in an atypical patient with no risk factors, likely due to untreated sinus infection.


Eli Goshorn, MD

Latest:

The Underlying Threat of Multidrug-Resistant Pathogens in the COVID-19 Era

Over half of patients admitted with positive SARS-CoV-2 testing received antibiotics, but evidence of bacterial infection is uncovered in far fewer cases. We may already be seeing the effects of antibiotic overprescribing.


Jessica Foley, PharmD, BCIDP

Latest:

Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.


Jaclyn O’Connor, PharmD

Latest:

Sticking It to COVID-19: The Expansion of the Pfizer-BioNTech Vaccine EUA

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.


Matthew Girgis, PHARMD, BCIDP

Latest:

So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?

Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.


James Donovan, MD

Latest:

Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart

"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "


Valencia Oglesby, DO

Latest:

Preparing for the Next Long-acting Antiretrovirals

Clinicians can make room for infrequent treatment options as patients enjoy their daily lives.




Paul Feuerstadt, MD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Anna Zhou, PharmD, BCIDP

Latest:

COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.


Alice Hemenway, PharmD, BCPS, BCIDP, MPH

Latest:

The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.


Jelena Lewis, PharmD, BCACP

Latest:

What’s New With Non–COVID-19 Vaccines

Although COVID-19 vaccination remains the primary focus for health care, other paramount vaccines need to be recognized. Here is a review.


Tavell Kindall, PhD, DNP, APRN, FNP

Latest:

Multidisciplinary Perspectives on HIV Treatment

A multidisciplinary panel concludes a discussion on best practices for managing patients with HIV in various healthcare settings and overcoming social health disparities.


Tina Tan, MD

Latest:

Practice Pearls for Treatment of Respiratory Infections

Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.


Meghan N. Jeffres, PharmD, BCIDP

Latest:

Antimicrobial Stewardship: More Is Better

A robust stewardship program requires a comprehensive investment in technology and staff.



Samuel L. Aitken, PharmD, MPH; and Cornelius J. Clancy, MD

Latest:

IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Since late 2004, 7 novel antibiotics with activity against ESBL-E, CRE, and/or DTR P aeruginosa have been approved.


Itay Klaz, MD, MHCI

Latest:

5 Strategies for Improving Sepsis Care Management

Hospitalists can be better equipped to identify patients most in need of intervention and standardize sepsis management efforts.



Kimberly Humphrey, MBBS, MPH

Latest:

Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.


Lina Meng, PharmD, BCIDP, BCCCP

Latest:

Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties

The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.


Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc

Latest:

Overview of SARS-CoV-2 Virus and Subvariants

Jacinda Abdul-Mutakabbir, PharmD, discusses the difference between the original SARS-CoV-2 strain and subvariant strains.


Joy Uzoma, PHARMD

Latest:

Bacterial Resistance Drives Need for New Therapies in Treating cUTIs in Adult Patients

Investigators examined the efficacy and safety of carbapenems vs select novel antibiotics for treatment of cUTI.


Sylvia Ou, PharmD

Latest:

A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt Infection

Rare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.


Conan MacDougall, PharmD, MAS, BCPS, BCIDP

Latest:

Children, COVID-19, and Another Crazy Respiratory Viral Season

Kevin J. Downes, MD, and Contagion® Section Editor Conan MacDougall, PharmD, MAS, BCPS, BCIDP, discuss these important topics as another season approaches.


Timothy Gauthier, PharmD, BCPS, BCIDP

Latest:

5 Ways Pharmacists Can Use Social Media For Professional Advancement

Social media involves information and content sharing and pharmacists can utilize the various platforms to enhance their professional needs and resources for their careers.




William Schaffner, MD

Latest:

Final Thoughts on COVID-19 and Flu

Final thoughts from experts on controlling COVID-19 and influenza.

© 2023 MJH Life Sciences

All rights reserved.